---
source_image: "legal-filing+invoice+spreadsheet__EFTA01377668_20260130_p001_i001.png"
source_pdf: "EFTA01377668.pdf"
method: pdf_text
words: 589
confidence: 1.00
extracted: 2026-02-13T17:09:13.393651
---

S-I/A 
(In thousands except share data) 
Cash and cash equivalents 
$ 174,083 
$ 174,083 
$ 
458.724 
Debt 
Convertible preferred stock, $0.0000001 par value per share; 135,339,499 
shares authorized, 135,252,809 issued and outstanding, actual; no shares 
authorized, issued and outstanding, pro forma and pro forma as adjusted 
514,945 
Shareholders' equity: 
Preferred stock, par value $0.0000001 per share; no shares authorized, issued 
and outstanding, actual; 100,000.000 shares authorized, no shares issued 
and outstanding, pro forma and pro forma as adjusted 
Existing common stock, par value 50.0000001 per share; 445,000,000 shares 
authorized, 156,742,206 shares issued and outstanding, actual; no shares 
authorized, issued and outstanding pro forma and pro forma as adjusted 
Class A common stock, par value 50.0000001 per share; no shares 
authorized, issued and outstanding, actual; 1,000,000,000 shares 
authorized, no shares issued and outstanding, pro forma; 1,000,000,000 
shares authorized, 27,000,000 issued and outstanding, pro forma as 
adjusted 
Class B common stock, par value 50.0000001 per share; no shares 
authorized, issued and outstanding, actual; 500,000.000 shares authorized, 
297,294,713 issued and outstanding, pro forma; 500,000,000 shares 
authorized. 295,944.713 issued and outstanding, pro forma as adjusted 
Additional paid-in capital 
249.954 
764,899 
1,049,540 
Accumulated other comprehensive loss 
(1,277) 
(1,277) 
(1,277) 
Accumulated deficit 
(527,160) 
(527,160) 
(527,160) 
Total stockholders' equity 
236.462 
236,462 
521,103 
Total capitalization 
$ 236,462 
$ 236,462 
$ 
521,103 
A $1.00 increase (decrease) in the assumed initial public offering price of $12.00 per share of Class A common stock, which 
is the mid-point of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) our 
pro forma as adjusted cash and cash equivalents, additional paid-in capital, total stockholders' equity, and total capitalization by 
approximately $24.3 million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus. 
remains the same, and after deducting estimated underwriting discounts and commissions. 
The number of shares of our Class A and Class B common stock to be outstanding after this offering is based on no shares 
of our Class A common stock and 297,294,713 shares of our Class B common stock (including preferred stock on an as-converted 
basis) outstanding as of September 30, 2015, and excludes the following: 
• 106,133,176 shares of our Class B common stock issuable upon the exercise of options to purchase shares of our Class B 
common stock outstanding as of September 30, 2015. with a weighted-average exercise price of $6.95 per share; 
55 
Table of Content% 
• 100,900 shares of our Class B common stock issuable upon the vesting of RSUs outstanding as of September 30, 2015; 
• 9,543,640 shares of our Class B common stock issuable upon the exercise of warrants outstanding as of September 30, 
2015, with a weighted-average exercise price of $10.92 per share: 
• 2.816.100 shares of our Class A common stock issuable upon the exercise of options to purchase shares of our Class A 
common stock granted after September 30, 2015. with an exercise price per share equal to the public offering price set 
forth on the cover page of the final prospectus for this offering; 
• 924.100 shares of our Class B common stock issuable upon the vesting of RSUs granted after September 30, 2015; 
• 1,940,058 shares of our Series E convertible preferred stock issued after September 30, 2015; and 
• 34.200.000 shares of our Class A common stock reserved for future issuance under our equity compensation plans, 
consisting of: 
http://www. sec. gov/A rehi vestedgaddata/1512673ANS11193125 I 5369092/d937622dsla.htm[11/6/2015 7:37:12 AM1 
CONFIDENTIAL - PURSUANT TO FED. R. GRIM. P. 6(e) 
CONFIDENTIAL 
DB-SDNY-0074819 
SDNY_GM_00221003 
EFTA01377668
